Palo Alto, CA
Exai Bio is a next-generation liquid biospy company. Exai bio proprietary RNA and artificial intelligence-based liquid biopsy platform deliver clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer.
exai.bioThese are collections Exai Bio is a part of. Click on the collection name to view similar companies.
Series A
$67,500,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Exai Bio.